Quarterly Results

  • Company Name :
Biocon Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532523
  • NSE Symbol:
  • BIOCON
  • P/E(TTM):
  • 0.00
  • ISIN Demat:
  • INE376G01013
  • Div & Yield%:
  • 0.11
  • EPS(TTM):
  • 0.60
  • Book Value(₹):
  • 119.54
  • Market Cap(₹Cr.):
  • 53,217.84
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 583.30 537.10 643.80
Excise Duty 0.00 0.00 0.00
Net Sales 583.30 537.10 643.80
Other Operating Income 0.00 0.00 0.00
Other Income 133.80 61.30 62.70
Total Income 717.10 598.40 706.50
Total Expenditure 530.40 516.50 581.80
PBIDT 186.70 81.90 124.70
Interest 67.20 56.20 56.70
PBDT 119.50 25.70 68.00
Depreciation 33.80 33.30 33.00
Tax 3.20 1.10 26.50
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 11.60 -0.40 -12.70
Reported Profit After Tax 70.90 -8.30 21.20
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 70.90 -8.30 21.20
EPS (Unit Curr.) 0.55 -0.07 0.18
EPS (Adj) (Unit Curr.) 0.55 -0.07 0.18
Calculated EPS (Unit Curr.) 0.53 -0.06 0.18
Calculated EPS (Adj) (Unit Curr.) 0.53 -0.06 0.18
Calculated EPS (Ann.) (Unit Curr.) 2.12 -0.25 0.71
Calculated EPS (Adj) (Ann.) (Unit Curr.) 2.12 -0.25 0.71
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 668.50 668.50 600.30
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 32.01 15.25 19.37
PBDTM(%) 20.49 4.78 10.56
PATM(%) 12.15 -1.55 3.29